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Introduction: Acute mesenteric ischemia (AMI) is a commonly fatal result of inadequate bowel perfusion that requires
immediate evaluation by both vascular and general surgeons. Treatment often involves vascular repair as well as bowel
resection and the possible need for parenteral nutrition. Little data exist regarding the rates of bowel resection following
endovascular vs open repair of AMI.
Methods:Using the National Inpatient Sample database, admissions from 2005 through 2009 were identiﬁed according to
International Classiﬁcation of Diseases, Ninth Revision codes correlating to both AMI (557.0) and subsequent vascular
intervention (39.26, 38.16, 38.06, 39.9, 99.10). Patients with a diagnosis of AMI but no intervention or nonemergent
admission status were excluded. Patient level data regarding age, gender, and comorbidities were also examined. Outcome
measures included mortality, length of stay, the need for bowel resection (45.6, 45.71-9, 45.8), or infusion of total
parenteral nutrition (TPN; 99.10) during the same hospitalization. Statistical analysis was conducted by c2 tests and
Wilcoxon rank-sum comparisons.
Results: Of 23,744 patients presenting with AMI, 4665 underwent interventional treatment from 2005 through 2009.
Of these patients, 57.1% were female, and the mean age was 70.5 years. A total of 679 patients underwent vascular
intervention; 514 (75.7%) underwent open surgery and 165 (24.3%) underwent endovascular treatment overall during
the study period. The proportion of patients undergoing endovascular repair increased from 11.9% of patients in 2005
to 30.0% in 2009. Severity of comorbidities, as measured by the Charlson index, did not differ signiﬁcantly between the
treatment groups. Mortality was signiﬁcantly more commonly associated with open revascularization compared with
endovascular intervention (39.3% vs 24.9%; P [ .01). Length of stay was also signiﬁcantly longer in the patient group
undergoing open revascularization (12.9 vs 17.1 days; P [ .006). During the study time period, 14.4% of patients
undergoing endovascular procedures required bowel resection compared with 33.4% for open revascularization
(P < .001). Endovascular repair was also less commonly associated with requirement for TPN support (13.7% vs
24.4%; P [ .025).
Conclusions: Endovascular intervention for AMI had increased signiﬁcantly in the modern era. Among AMI patients
undergoing revascularization, endovascular treatment was associated with decreased mortality and shorter length of stay.
Furthermore, endovascular intervention was associated with lower rates of bowel resection and need for TPN. Further
research is warranted to determine if increased use of endovascular repair could improve overall and gastrointestinal
outcomes among patients requiring vascular repair for AMI. (J Vasc Surg 2014;59:159-64.)Acute mesenteric ischemia (AMI) is the result of
compromised bowel perfusion through embolic, throm-
botic, and nonocclusive disease of the mesenteric vascula-
ture. It represents an uncommon (0.1% to 0.2% of all
hospitalizations), but extremely deadly vascular malady.1
Further, diagnosis of AMI remains difﬁcult, with the
most common presenting symptom being acute-onset
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mortality for those affected remains staggeringly high.3,4
The vascular surgeon has both endovascular and open
options for the treatment of AMI. The use of endovascular
repair has been increasing in the past decade, but there still
remains a large discrepancy in practice patterns, with the
majority of patients receiving open repair by embolectomy
and arterial bypass.5 Patients with bowel ischemia limited
to speciﬁc vascular domains, as opposed to widespread
necrosis, may undergo bowel resection as well, with
a near 30% mortality and 60% morbidity rate.6 To date,
limited information exists comparing the method of repair
and the number of patients requiring bowel resection and
need for enteral replacement therapies. Therefore, the
objective of this study is to compare the rates of gastroin-
testinal outcomes in patients treated via open and endovas-
cular approaches for AMI.
METHODS
The study was approved by the Institutional Review
Board of the Johns Hopkins Hospital. The Nationwide
Inpatient Sample (NIS) database is a national survey of159
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States, representing approximately 20% of inpatient hospi-
talizations at nongovernment hospitals. The database was
queried using International Classiﬁcation of Disease and
Injury, version 9 (ICD-9) codes in a stepwise manner.
First, patients with an ICD-9 code correlating with AMI
(557.0) were selected from the calendar years 2005
through 2009. Patients were then further selected for
codes 39.26 (intra-abdominal shunt or vascular bypass),
endarterectomy of abdominal arteries (38.16), incision of
abdominal arteries (38.06), insertion of nondrug-eluting
vascular stents (39.90), and injection or infusion of throm-
bolytic substance (99.10). Patient-level data regarding the
need for bowel resection was also obtained using codes
designating resection of small bowel (45.6), excision of
large bowel (45.71-9), and total intrabdominal colectomy
(45.7), as well as patients requiring support with total
parenteral nutrition (TPN; 99.15). Patients with a diagnosis
of AMI but who did not undergo one of the listed proce-
dures were excluded. Further, patients with an admission
status listed as “elective” were excluded from the database.
Patient-speciﬁc demographics were collected for all
remaining patients after exclusion criteria were applied.
Data regarding age, gender, status of admission (elective
vs emergent), and presence of signiﬁcant comorbidities
were collected. Comorbidities examined included hyper-
tension, hyperlipidemia, cardiovascular disease, peripheral
vascular disease, cerebrovascular disease, renal dysfunction,
congestive heart failure, and obstructive pulmonary disease.
A patient’s total disease burden was calculated using the
Charlson Index. Patients in each cohort were also queried
for the presence of lactic acidosis (272.6), hypotension
(458.9), systemic inﬂammatory reaction syndrome (995.91),
and acute respiratory distress syndrome (ARDS; 518.5) as
surrogate measures of acute severity of illness. Outcomes
measured were mortality, length of stay, performance of
bowel resection during hospitalization, and requirement
for TPN infusion. Patient demographics and outcomes
were weighted to the population.
Statistical analysis. Statistical analysis between groups
was carried out with c2 tests to examine categorical and
dichotomous variables. Continuous variables were com-
pared using Wilcoxon rank-sum tests for signiﬁcance of
variance between the two groups.
RESULTS
Patient data. A total of approximately 40,000,000
hospitalizations during 2005 through 2009 were exam-
ined, yielding 23,744 patients with AMI for the applicable
years. Of patients presenting with AMI, 4655 (19.6%)
patients underwent intervention during their hospitaliza-
tion, with 679 (14.6%) patients treated with revasculariza-
tion. Open vascular surgery was performed in 514 (75.7%)
patients and endovascular repair in 165 (24.3%) patients
over the study period (Fig). Patients with Current Proce-
dural Terminology codes corresponding to both open and
endovascular procedures were analyzed within the endo-
vascular cohort. Among the cohort of patients listed asemergent and undergoing intervention, there was an
increase in the number of patients with hyperlipidemia.
There was an increase in the proportion of vascular repairs
performed by endovascular techniques when comparing
the ﬁrst and last years of the queried period (11.9% vs
30.0%; P < .001). Patient demographics did not differ
signiﬁcantly between patients treated with open and
endovascular repair (Table I). There were similar rates of
systemic inﬂammatory reaction syndrome and hypotension
among open and endovascular intervention cohorts (6.58%
vs 4.88%; P ¼ .54, and 4.93% vs 5.90%; P ¼ .7, respec-
tively). The group who underwent open intervention did
have higher rates of lactic acidosis and ARDS when
compared with the endovascular group (30.0% vs 11.4%;
P ¼ .002 and 31.5% vs 7.0%; P < .001, respectively;
Table II).
Outcomes. There was an increased incidence of death
seen in the patients undergoing open revascularization
compared with the endovascular repair (39.3% vs 24.9%;
P ¼ .01). Endovascular repair was associated with
a decreased length of stay (12.9 vs 17.1 days; P ¼ .006).
The time from admission to procedure was 1.86 days
(conﬁdence interval, 1.45-2.26 days) for endovascular
repair and 1.99 days (conﬁdence interval, 1.42-2.55 days)
for open repair, and did not differ signiﬁcantly between
groups (P ¼ .72). Comparison of patients undergoing
vascular intervention revealed a signiﬁcantly higher propor-
tion of patients undergoing bowel resection with open
vascular repair compared with endovascular repair (33.4%
vs 14.4%, respectively; P < .001). Comparison of TPN
use in the openly repaired patients compared with the
endovascular group demonstrated a statistically signiﬁcant
higher rate among patients undergoing open repair
(24.4% vs 14.7%; P ¼ .025; Table III).
DISCUSSION
Mortality among patients presenting with AMI remains
alarmingly high despite signiﬁcant changes in vascular
therapy over the past several decades. Factors that con-
tribute to the inability to improve upon outcomes include
relative rarity of the disease, and signiﬁcant comorbidities
present in many patients with AMI. In our study, nearly
half of the patients with AMI had hypertension, and greater
than 20% had hyperlipidemia with a similar incidence of
cardiovascular disease. Further, an increasing number of
patients had signiﬁcant renal disease at the time of presen-
tation. These comorbidities combined for a Charlson Index
ranging from 1.13 to 1.53, predicting a 1-year mortality of
approximately 25%.7 The combination of high comorbid
disease burden, delay in diagnosis, and pathologic derange-
ment associated with AMI has led to devastatingly high
rates of mortality. According to early literature, 75% of
patients will succumb to their disease.8 These early esti-
mates are further supported by more contemporary anal-
yses purporting 60% to 80% mortality (Table IV).1,4,9
Kougias et al demonstrate a survival beneﬁt among patients
who undergo early revascularization, with a large cohort
(22%-53%) undergoing bowel resection, with a 30-day
Fig. Flow chart demonstrating grouping algorithm for the National Inpatient Study (NIS) database search. AMI,
Acute mesenteric ischemia; CPT, Current Procedural Terminology.
Table I. Demographic and patient data (weighted to the U.S. population)
2005 (n ¼ 331),
No. (%)
2006 (n ¼ 446),
No. (%)
2007 (n ¼ 324),
No. (%)
2008 (n ¼ 474),
No. (%)
2009 (n ¼ 424),
No. (%) P value
Age,a years 70.5 6 1.7 69.18 6 1.5 67.9 6 2.2 68.7 6 1.5 66.6 6 1.7
Female 161 (48.6) 297 (66.6) 185 (57.1) 281 (59.1) 218 (51.3) .17
Hypertension 104 (31.3) 175 (39.2) 149 (45.9) 179 (37.6) 176 (41.5) .52
Hyperlipidemia 19 (6.0) 34 (7.5) 33 (10.2) 96.3 (20.3) 49 (11.6) .03
Cardiovascular disease 54 (16.2) 104 (23.3) 97 (29.9) 111 (23.3) 106 (24.9) .48
Peripheral vascular disease 35 (10.5) 46 (10.3) 43 (13.2) 70 (14.8) 36 (8.4) .70
Cerebrovascular disease 15 (4.6) 25 (5.6) 22 (6.7) 43 (9.1) 30 (7.2) .82
Renal disease 11 (3.2) 52 (11.6) 10 (3.2) 36 (7.5) 33 (7.7) .23
Congestive heart failure 50 (15.1) 76 (16.9) 129 (39.8) 85 (18.0) 58 (13.7) <.001
Obstructive pulmonary disease 100 (30.2) 91 (20.5) 67 (20.6) 72 (15.3) 96 (22.7) .26
Charlson Indexa 1.13 6 0.12 1.30 6 0.14 1.53 6 0.22 1.47 6 0.16 1.49 6 0.17
aMean 6 standard deviation.
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relationship with time-to-diagnosis, increasing mortality
to 70% among patients with a delay of greater than
24 hours.12 Conversely, in patients undergoing surgical
management within 12 hours of symptom onset, mortality
rates remain encouragingly low (14%).10
Critical damage sustained by small bowel associated
with AMI plays an important role in the management
and prognosis of patients with AMI. Patients who undergo
bowel resection may appreciate a survival beneﬁt, reducing
mortality and morbidity to 30% and 60%, respectively.6
However, the need for bowel resection at second-looklaparotomy was found to be an independent predictor of
mortality among patients undergoing surgical intervention
for AMI.10 Series looking at small bowel resections may be
subject to a “selection bias,” ruling out patients with
necrosis too extensive to warrant further intervention. In
our analysis, open surgery is more commonly associated
with bowel resection when compared with endovascular
repair (29.8% vs 12.1%; P < .001). Patients who under-
went open repair were also more likely to have a concomi-
tant diagnosis of lactic acidosis compared with those
undergoing vascular repair. While difﬁcult to draw conclu-
sions regarding the reasoning behind the choice to pursue
Table II. Measurements of acute illness severity in
treatment groups
Open (n ¼ 1499),
No. (%)
Endovascular (n ¼ 502),
No. (%)
P
value
Lactic
acidosis
404 (30.0) 57 (11.4) .0018
Hypotension 99 (6.6) 25 (4.9) .54
SIRS 74 (4.9) 30 (5.9) .70
ARDS 472 (31.5) 35 (7.0) <.001
ARDS, Acute respiratory distress syndrome; SIRS, systemic inﬂammatory
reaction syndrome.
Table III. Outcomes (weighted)
Open (n ¼ 1495),
No. (%)
Endovascular (n ¼ 502),
No. (%)
P
value
Mortality 587 (39.3) 125 (24.9) .010
Bowel
resection
500.5 (33.4) 72.5 (14.4) <.001
TPN 365.4 (24.4) 68.6 (13.7) .025
Length of
stay,a days
17.1 6 1.07 12.9 6 1.11 .006
TPN, Total parenteral nutrition.
aMean 6 standard deviation.
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nosis that portends an increased likelihood of requiring
open repair and bowel resection. While patients with signif-
icant at-risk bowel may preferentially undergo open repair,
approaches emphasizing endovascular intervention ﬁrst fol-
lowed by observant management for bowel involvement
have increased in popularity recently.5
There is a direct relationship between prolonged times
to diagnosis and bowel viability, with 100% of patients with
symptoms lasting less than 12 hours having viable intestine
at exploration.13,14 Within this analysis, lactic acidosis and
time to treatment help to characterize this particular infor-
mation regarding patient presentation. While there was no
difference in the time to treatment, patients in the open
repair group did demonstrate higher rates of lactic acidosis
during their hospital stay. However, this analysis is limited
in its ability to qualify when this diagnosis is assigned
during the admission. Yet, this may represent an identiﬁca-
tion of at-risk patients, who may have been preferably
treated with open repair. As a representative surrogate for
morbidity, rates of TPN infusion were also signiﬁcantly
greater among patients undergoing open repair (24.4% vs
13.7%; P ¼ .025). While TPN infusion may occur inde-
pendent of bowel resection (ie, as a method for providing
bowel rest), Arthurs et al showed a signiﬁcant increase in
the length of small bowel resected in patients undergoing
open revascularization for AMI (160 cm vs 59 cm), which
may increase the risks of requiring TPN.15
Endovascular therapy has gained increasing popularity
as a treatment modality for AMI. In our review, there
was a signiﬁcant increase in the utilization of endovasculartherapy (angioplasty, stenting, or thrombolysis) during the
study period, more than doubling from 11.9% in 2005 to
30% in 2009. Historically, endovascular repair has been
reserved for the targeted infusion of thrombolytic agents
for the treatment of nonocclusive mesenteric ischemia.
Primarily, these patients are managed with anticoagulation
and antiplatelet therapy, although regimens utilizing the
plieotropic effects of cilostazol may be beneﬁcial.16,17 Arte-
riography, as a diagnostic mechanism, can aid in the visual-
ization of affected vascular beds and site of occlusion but
was not included as an operative procedure in our analysis.
However, the indications for endovascular repair may be
expanding. Recent literature reports an 87% technical
success rate for endovascular therapy.15 Although there
is likely some selection bias in patients receiving endovascu-
lar therapy compared with open therapy, we failed to ﬁnd
a difference in observed demographic variables among
the two treatment groups. However, there still exists the
possibility of selection bias being related to anatomic
factors, which cannot be appropriately captured within
the NIS dataset. Further, there were high rates of lactic
acidosis and ARDS in patients undergoing open repair
compared with endovascular. As stated earlier, this may
suggest a possible worse initial presentation among patients
who ultimately undergo open repair; however, the NIS
database precludes making conclusions as to the timing
of these diagnoses in the patients’ hospitalization. As
such, the better survival of the endovascular therapy vs
open surgical therapy for AMI (14.9% vs 39.3%; P ¼ .01)
cannot be fully determined to reﬂect selection bias, espe-
cially considering equivalent time from admission to
primary therapy. In particular, this work suggests that lactic
acidosis may have important prognostic implications for
gastrointestinal outcomes and value in directing the initial
management pathway.
Initial experience with endovascular therapy for AMI
was tempered for concern of a possible delay in time to de-
ﬁnitive operation. However, recent literature has reported
an acceptable time to treatment when endovascular therapy
is coupled with computed tomography angiography.18 As
discussed previously, given the evidence for increasing
mortality seen with increasing time diagnosis, this suggests
a possible mechanism for worse outcomes among endovas-
cular patients. In our analysis, the time from admission to
primary therapy did not differ signiﬁcantly between the
groups (1.86 vs 1.99 days; P ¼ .72). Within both groups,
the time to treatment is still longer than previously recom-
mended paradigms. This may represent a possible reason
for the rates of increased bowel resection among patients
undergoing open repair. Further, when considering pos-
sible biases in the selection of patients, this delay may repre-
sent a “trial” period in which more favorable patients were
observed before undergoing intervention, improving the
overall observed endovascular outcomes. AMI remains
a vascular emergency, with mortality directly correspond-
ing to the time to diagnosis and treatment.12
This study has a number of important limitations. The
NIS does not include several important data points
Table IV. Review of current results with acute mesenteric ischemia (AMI)
Author (year) No. Open Mortality Endovascular Mortality P
Mamode (1999) 57 36 69% (25)
Park (2002) 58 58 32% (19) 30 days
41% (24) 90 days
8
All patients proceeded
to open
75% (6)
Edwards (2003) 76 174 62% (46) perioperative 2 Not reported
Acosta-Merida (2006) 132 132 65.2% (86)
Kougias (2007) 72 72 26% (19) 30 days
Kassahun (2008) 60 60 60% (36)
Newton (2011) 142 142 30% (43) 30 days
Arthurs (2011) 70 14 50% (7) 56 39% (22)
Endovascular only:
36% (18)
.15
<.05
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ization type on patient outcome. Notably, these include
the lack of information regarding timing of intervention
in relation to diagnosis and ordering of procedures for
hospitalizations during which multiple procedures were
performed. While patients with Current Procedural Termi-
nology codes corresponding to both endovascular and
open repair were grouped among the endovascular cohort,
the NIS dataset does not allow for determination of reason
for switching approach. This limits the ability to classify if
anatomically “unsuitable” patients, determined at the
time of intervention, were preferentially switched to open
repair. Also, the initial search for AMI (ICD-9 code
557.0) yielded approximately 24,000 instances of AMI.
As the NIS database represents only 20% of all inpatient
hospitalizations in the United States, weighted analysis
would make this incidence even more prevalent. Given
the reported rarity of AMI, these incidences would seem
elevated and may comment to the overall accuracy of
querying the NIS database by a single variable. Within
the NIS dataset, there is also the inability to separate the
multiple etiologies of AMI, including embolic, thrombotic,
venous, and nonocclusive. Given the differences in
mortality rates among these pathophysiologic entities, their
grouping may confound the outcomes observed here.
Searching only for patients who underwent intervention,
more commonly associated with thrombotic and embolic
etiologies, may help to reduce the impact of this limitation,
but this cannot completely exclude venous and nonocclu-
sive causes of AMI. Finally, reports of mortality are per
hospitalization only, and therefore may underestimate
overall mortality from this disease entity and confuse
comparison with previously described 30-day, 1-year, and
3-year mortality periods.CONCLUSIONS
We have demonstrated endovascular intervention in
AMI has increased substantially in the modern era and is
less commonly associated with mortality, bowel resection,
and the use of TPN in a cohort of patients with similar
baseline characteristics to those undergoing open repair.This is further supported by recent literature reporting
success in using endovascular therapy for AMI. However,
rates of overall mortality remain alarmingly high. Further
research is needed to best identify patterns of presentation
and characteristics of patients that would most beneﬁt from
endovascular or open repair in AMI.
AUTHOR CONTRIBUTIONS
Conception and design: RB, CA, ES, JB
Analysis and interpretation: RB, CA, ES, JB
Data collection: RB, ES
Writing the article: RB, ES, DA, DE, JB
Critical revision of the article: RB, ES, JB
Final approval of the article: JB
Statistical analysis: RB, ES
Obtained funding: JB
Overall responsibility: JB
REFERENCES
1. Stoney R, Cunningham C. Acute mesenteric ischemia. Surgery
1993;114:489-90.
2. Park WM, Gloviczki P, Cherry KJ Jr, Hallett JW Jr, Bower TC,
Panneton JM, et al. Contemporary management of acute mesenteric
ischemia: Factors associated with survival. J Vasc Surg 2002;35:445-52.
3. Mamode N, Pickford I, Leiberman P. Failure to improve outcome in
acute mesenteric ischaemia: seven-year review. Eur J Surg 1999;165:
203-8.
4. Kassahun WT, Schulz T, Richter O, Hauss J. Unchanged high
mortality rates from acute occlusive intestinal ischemia: six year review.
Langenbecks Arch Surg 2008;393:163-71.
5. Ryer EJ, Kalra M, Oderich GS, Duncan AA, Gloviczki P, Cha S, et al.
Revascularization for acute mesenteric ischemia. J Vasc Surg 2012;55:
1682-9.
6. Gupta PK, Natarajan B, Gupta H, Fang X, Fitzgibbons RJ. Morbidity
and mortality after bowel resection for acute mesenteric ischemia.
Surgery 2011;150:779-87.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of
classifying prognostic comorbidity in longitudinal studies: development
and validation. J Chronic Dis 1987;40:373-83.
8. Khan A, Rubinstein P. Ischemic bowel disease: diagnosis and prog-
nosis. Geriatrics 1984;39:63-5.
9. Debus ES, Müller-Hülsbeck S, Kölbel T, Larena-Avellaneda A. Intes-
tinal ischemia. Int J Colorectal Dis 2011;26:1087-97.
10. Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH.
Determinants of mortality and treatment outcome following surgical
JOURNAL OF VASCULAR SURGERY
164 Beaulieu et al January 2014interventions for acute mesenteric ischemia. J Vasc Surg 2007;46:
467-74.
11. Parks AG, Stitz RW. The treatment of high ﬁstula-in-ano. Dis Colon
Rectum 1976;19:487-99.
12. Oldenburg W, Lau L, Rodenberg T, Edmonds H, Burger C. Acute
mesenteric ischemia: a clinical review.ArchInternMed2004;164:1054-62.
13. Lobo Martinez E, Carvajosa E, Sacco O, Martinez Molina E. Embo-
lectomy in mesenteric ischemia. Rev Esp Enferm Dig 1993;83:351-4.
14. Wadman M, Syk I, Elmstahl S. Survival after operation for ischemic
bowel disease. Eur J Surg 2000;166:872-7.
15. Arthurs ZM, Titus J, Bannazadeh M, Eagleton MJ, Srivastava S,
Sarac TP, et al. A comparison of endovascular revascularization withtraditional therapy for the treatment of acute mesenteric ischemia.
J Vasc Surg 2011;53:698-704; discussion: 704-5.
16. Sreenarasimhaiah J. Diagnosis and management of intestinal ischaemic
disorders. BMJ 2003;326:1372-6.
17. Sudharshana Murthy K, Kiran H, Cheluvaraj V, Bhograj A. Non-
occlusive mesenteric ischemia and the role of cilostazol in its
management. J Pharmacol Pharmacother 2012;3:68-70.
18. Resch TA, Acosta S, Sonesson B. Endovascular techniques in acute
arterial mesenteric ischemia. Semin Vasc Surg 2010;23:29-35.Submitted Feb 19, 2013; accepted Jun 20, 2013.
